Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02773849 |
|---|---|
| Brief Title: | ADSTILADRIN (=INSTILADRIN) in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) |
| First Submitted : | April 19, 2016 |
| First Submitted that Met QC Criteria : | May 12, 2016 |
| First Posted : | May 16, 2016 (Estimate) |
| Results First Submitted : | May 11, 2022 |
| Results First Submitted that Met QC Criteria : | June 17, 2022 |
| Results First Posted : | July 13, 2022 |
| Certification/Extension First Submitted : | May 11, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | May 11, 2020 |
| Certification/Extension First Posted : | May 13, 2020 |
| Last Update Submitted that Met QC Criteria : | December 20, 2023 |
| Last Update Posted : | December 22, 2023 |